Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
about
Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dipeptidyl peptidase-4 inhibit ...... of randomized clinical trials.
@en
type
label
Dipeptidyl peptidase-4 inhibit ...... of randomized clinical trials.
@en
prefLabel
Dipeptidyl peptidase-4 inhibit ...... of randomized clinical trials.
@en
P2093
P2860
P1433
P1476
Dipeptidyl peptidase-4 inhibit ...... of randomized clinical trials
@en
P2093
Daud M Rahmani
Fuyan Wang
Jiayi Chen
Xiaolong Lai
Yanyan Yuan
Zuquan Zou
P2860
P2888
P356
10.1038/S41598-017-07921-2
P407
P50
P577
2017-08-15T00:00:00Z